Cours Kaneh Bosm Biotechnology Inc Canadian Securities Exchange
Actions
CA4841902022
Pharmacies
CA 2018 | - | CA 2019 | - | Capitalisation | 13,23 M 18,13 M 12,34 M |
---|---|---|---|---|---|
Résultat net 2018 | - 0 0 | Résultat net 2019 | -60 M -82,21 M -55,96 M | VE / CA 2018 * | - |
Trésorerie nette 2018 * | - 0 0 | Trésorerie nette 2019 * | - 0 0 | VE / CA 2019 * | - |
PER 2018 * |
-
| PER 2019 * |
-
| Employés | - |
Rendement 2018 * |
-
| Rendement 2019 * |
-
| Flottant | 0 % |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
David Shpilt
CEO | Chief Executive Officer | - | 15/04/19 |
Eugene Beukman
BRD | Director/Board Member | 64 | 27/04/18 |
Corporate Officer/Principal | - | 25/04/19 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Eugene Beukman
BRD | Director/Board Member | 64 | 27/04/18 |
Matthew Fish
BRD | Director/Board Member | - | 29/05/19 |
Varia. 1 janv. | Capi. | |
---|---|---|
+7,40 % | 2,76 Md | |
-21,77 % | 1,16 Md | |
+47,99 % | 503 M | |
-12,27 % | 411 M | |
+61,50 % | 202 M | |
-1,11 % | 95,1 M | |
+41,57 % | 57,08 M |